A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 5,331,760 shares of ABT stock, worth $554 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
5,331,760
Previous 5,159,295 3.34%
Holding current value
$554 Million
Previous $568 Million 6.71%
% of portfolio
0.42%
Previous 0.43%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$109.52 - $120.96 $18.9 Million - $20.9 Million
172,465 Added 3.34%
5,331,760 $606 Million
Q4 2023

Jan 30, 2024

BUY
$90.19 - $110.4 $7.34 Million - $8.99 Million
81,392 Added 1.6%
5,159,295 $568 Million
Q3 2023

Oct 30, 2023

SELL
$95.53 - $114.62 $2.94 Million - $3.53 Million
-30,787 Reduced 0.6%
5,077,903 $492 Million
Q2 2023

Jul 31, 2023

SELL
$100.78 - $112.29 $90.1 Million - $100 Million
-893,704 Reduced 14.89%
5,108,690 $557 Million
Q1 2023

Apr 27, 2023

BUY
$96.86 - $114.01 $29.1 Million - $34.2 Million
300,188 Added 5.26%
6,002,394 $608 Million
Q4 2022

Jan 30, 2023

SELL
$95.06 - $111.52 $2.74 Million - $3.21 Million
-28,791 Reduced 0.5%
5,702,206 $626 Million
Q3 2022

Oct 21, 2022

SELL
$96.76 - $112.03 $1.69 Million - $1.95 Million
-17,435 Reduced 0.3%
5,730,997 $555 Million
Q2 2022

Jul 26, 2022

BUY
$102.07 - $123.37 $18.1 Million - $21.8 Million
176,912 Added 3.18%
5,748,432 $625 Million
Q1 2022

Apr 27, 2022

SELL
$114.02 - $139.04 $18 Million - $22 Million
-157,916 Reduced 2.76%
5,571,520 $659 Million
Q4 2021

Feb 02, 2022

SELL
$115.53 - $141.46 $19.9 Million - $24.4 Million
-172,383 Reduced 2.92%
5,729,436 $806 Million
Q3 2021

Oct 25, 2021

SELL
$116.66 - $129.06 $24.9 Million - $27.5 Million
-213,383 Reduced 3.49%
5,901,819 $697 Million
Q2 2021

Aug 02, 2021

SELL
$105.79 - $124.53 $20.6 Million - $24.3 Million
-194,934 Reduced 3.09%
6,115,202 $709 Million
Q1 2021

Apr 30, 2021

BUY
$108.84 - $128.23 $47.7 Million - $56.2 Million
438,576 Added 7.47%
6,310,136 $756 Million
Q4 2020

Feb 05, 2021

SELL
$105.0 - $114.42 $86.5 Million - $94.2 Million
-823,453 Reduced 12.3%
5,871,560 $643 Million
Q3 2020

Oct 30, 2020

SELL
$91.64 - $111.29 $40.9 Million - $49.7 Million
-446,155 Reduced 6.25%
6,695,013 $729 Million
Q2 2020

Jul 27, 2020

SELL
$76.57 - $98.0 $9.06 Million - $11.6 Million
-118,375 Reduced 1.63%
7,141,168 $650 Million
Q1 2020

Apr 27, 2020

BUY
$62.82 - $91.86 $23.8 Million - $34.8 Million
379,014 Added 5.51%
7,259,543 $570 Million
Q4 2019

Jan 31, 2020

SELL
$78.51 - $87.4 $2.11 Million - $2.34 Million
-26,812 Reduced 0.39%
6,880,529 $595 Million
Q3 2019

Oct 31, 2019

BUY
$81.84 - $88.74 $7.37 Million - $7.99 Million
90,060 Added 1.32%
6,907,341 $578 Million
Q2 2019

Jul 29, 2019

BUY
$72.88 - $85.0 $5.33 Million - $6.21 Million
73,074 Added 1.08%
6,817,281 $573 Million
Q1 2019

May 08, 2019

BUY
$66.22 - $80.06 $3.82 Million - $4.62 Million
57,702 Added 0.86%
6,744,207 $539 Million
Q4 2018

Feb 06, 2019

BUY
$65.56 - $74.27 $68.1 Million - $77.2 Million
1,039,045 Added 18.4%
6,686,505 $475 Million
Q3 2018

Nov 07, 2018

BUY
$60.81 - $73.36 $9.49 Million - $11.4 Million
156,040 Added 2.84%
5,647,460 $414 Million
Q2 2018

Aug 01, 2018

BUY
$57.57 - $63.54 $22.4 Million - $24.7 Million
388,546 Added 7.61%
5,491,420 $335 Million
Q1 2018

May 01, 2018

BUY
$56.27 - $63.62 $2.49 Million - $2.82 Million
44,314 Added 0.88%
5,102,874 $306 Million
Q4 2017

Feb 06, 2018

BUY
$53.68 - $57.47 $6.23 Million - $6.67 Million
116,028 Added 2.35%
5,058,560 $289 Million
Q3 2017

Nov 07, 2017

SELL
$48.06 - $53.64 $457,098 - $510,170
-9,511 Reduced 0.19%
4,942,532 $264 Million
Q2 2017

Aug 07, 2017

BUY
N/A
4,952,043
4,952,043 $241 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.